{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T21:29:57Z","timestamp":1792704597518,"version":"4.5.0"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2009,4,12]],"date-time":"2009-04-12T00:00:00Z","timestamp":1239494400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Nat Med"],"published-print":{"date-parts":[[2009,5]]},"DOI":"10.1038\/nm.1903","type":"journal-article","created":{"date-parts":[[2009,4,12]],"date-time":"2009-04-12T17:44:23Z","timestamp":1239558263000},"page":"566-571","source":"Crossref","is-referenced-by-count":97,"title":["Nanofluidic proteomic assay for serial analysis of oncoprotein activation in clinical specimens"],"prefix":"10.1038","volume":"15","author":[{"given":"Alice C","family":"Fan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Debabrita","family":"Deb-Basu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mathias W","family":"Orban","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jason R","family":"Gotlib","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasodha","family":"Natkunam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roger","family":"O'Neill","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rose-Ann","family":"Padua","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liwen","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daryl","family":"Taketa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amy E","family":"Shirer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shelly","family":"Beer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ada X","family":"Yee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David W","family":"Voehringer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dean W","family":"Felsher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2009,4,12]]},"reference":[{"key":"BFnm1903_CR1","doi-asserted-by":"publisher","first-page":"850","DOI":"10.1038\/35057046","volume":"409","author":"PA Futreal","year":"2001","unstructured":"Futreal, P.A. et al. Cancer and genomics. Nature 409, 850\u2013852 (2001).","journal-title":"Nature"},{"key":"BFnm1903_CR2","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1038\/427201a","volume":"427","author":"H Harris","year":"2004","unstructured":"Harris, H. Tumour suppression: putting on the brakes. Nature 427, 201 (2004).","journal-title":"Nature"},{"key":"BFnm1903_CR3","doi-asserted-by":"publisher","first-page":"636","DOI":"10.1038\/436636a","volume":"436","author":"NE Sharpless","year":"2005","unstructured":"Sharpless, N.E. & DePinho, R.A. Cancer: crime and punishment. Nature 436, 636\u2013637 (2005).","journal-title":"Nature"},{"key":"BFnm1903_CR4","doi-asserted-by":"publisher","first-page":"789","DOI":"10.1038\/nm1087","volume":"10","author":"B Vogelstein","year":"2004","unstructured":"Vogelstein, B. & Kinzler, K.W. Cancer genes and the pathways they control. Nat. Med. 10, 789\u2013799 (2004).","journal-title":"Nat. Med."},{"key":"BFnm1903_CR5","doi-asserted-by":"publisher","first-page":"7824","DOI":"10.1073\/pnas.79.24.7824","volume":"79","author":"R Dalla-Favera","year":"1982","unstructured":"Dalla-Favera, R. et al. Human c-myc onc gene is located on the region of chromosome 8 that is translocated in Burkitt lymphoma cells. Proc. Natl. Acad. Sci. USA 79, 7824\u20137827 (1982).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"BFnm1903_CR6","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1634\/theoncologist.11-4-375","volume":"11","author":"JA Ferry","year":"2006","unstructured":"Ferry, J.A. Burkitt's lymphoma: clinicopathologic features and differential diagnosis. Oncologist 11, 375\u2013383 (2006).","journal-title":"Oncologist"},{"key":"BFnm1903_CR7","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1016\/j.ccr.2005.08.005","volume":"8","author":"CV Dang","year":"2005","unstructured":"Dang, C.V., O'Donnell, K.A. & Juopperi, T. The great MYC escape in tumorigenesis. Cancer Cell 8, 177\u2013178 (2005).","journal-title":"Cancer Cell"},{"key":"BFnm1903_CR8","doi-asserted-by":"publisher","first-page":"1440","DOI":"10.1126\/science.3874430","volume":"228","author":"Y Tsujimoto","year":"1985","unstructured":"Tsujimoto, Y., Cossman, J., Jaffe, E. & Croce, C.M. Involvement of the bcl-2 gene in human follicular lymphoma. Science 228, 1440\u20131443 (1985).","journal-title":"Science"},{"key":"BFnm1903_CR9","first-page":"42","volume":"27","author":"L Bordeleau","year":"2000","unstructured":"Bordeleau, L. & Berinstein, N.L. Molecular diagnostics in follicular non-Hodgkin's lymphoma: a review. Semin. Oncol. 27, 42\u201352 (2000).","journal-title":"Semin. Oncol."},{"key":"BFnm1903_CR10","doi-asserted-by":"publisher","first-page":"1079","DOI":"10.1126\/science.2408149","volume":"247","author":"TG Lugo","year":"1990","unstructured":"Lugo, T.G., Pendergast, A.M., Muller, A.J. & Witte, O.N. Tyrosine kinase activity and transformation potency of bcr-abl oncogene products. Science 247, 1079\u20131082 (1990).","journal-title":"Science"},{"key":"BFnm1903_CR11","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1038\/nrc2147","volume":"7","author":"JV Melo","year":"2007","unstructured":"Melo, J.V. & Barnes, D.J. Chronic myeloid leukaemia as a model of disease evolution in human cancer. Nat. Rev. Cancer 7, 441\u2013453 (2007).","journal-title":"Nat. Rev. Cancer"},{"key":"BFnm1903_CR12","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1038\/nrc2126","volume":"7","author":"E Weisberg","year":"2007","unstructured":"Weisberg, E., Manley, P.W., Cowan-Jacob, S.W., Hochhaus, A. & Griffin, J.D. Second generation inhibitors of BCR-ABL for the treatment of imatinib-resistant chronic myeloid leukaemia. Nat. Rev. Cancer 7, 345\u2013356 (2007).","journal-title":"Nat. Rev. Cancer"},{"key":"BFnm1903_CR13","doi-asserted-by":"publisher","first-page":"1200","DOI":"10.1038\/sj.leu.2401467","volume":"13","author":"S Ghaffari","year":"1999","unstructured":"Ghaffari, S., Daley, G.Q. & Lodish, H.F. Growth factor independence and BCR\/ABL transformation: promise and pitfalls of murine model systems and assays. Leukemia 13, 1200\u20131206 (1999).","journal-title":"Leukemia"},{"key":"BFnm1903_CR14","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1038\/nrc1070","volume":"3","author":"DW Felsher","year":"2003","unstructured":"Felsher, D.W. Cancer revoked: oncogenes as therapeutic targets. Nat. Rev. Cancer 3, 375\u2013380 (2003).","journal-title":"Nat. Rev. Cancer"},{"key":"BFnm1903_CR15","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/j.semcancer.2003.11.002","volume":"14","author":"S Giuriato","year":"2004","unstructured":"Giuriato, S., Rabin, K., Fan, A.C., Shachaf, C.M. & Felsher, D.W. Conditional animal models: a strategy to define when oncogenes will be effective targets to treat cancer. Semin. Cancer Biol. 14, 3\u201311 (2004).","journal-title":"Semin. Cancer Biol."},{"key":"BFnm1903_CR16","doi-asserted-by":"publisher","first-page":"1031","DOI":"10.1056\/NEJM200104053441401","volume":"344","author":"BJ Druker","year":"2001","unstructured":"Druker, B.J. et al. Efficacy and safety of a specific inhibitor of the BCR-ABL tyrosine kinase in chronic myeloid leukemia. N. Engl. J. Med. 344, 1031\u20131037 (2001).","journal-title":"N. Engl. J. Med."},{"key":"BFnm1903_CR17","doi-asserted-by":"publisher","first-page":"645","DOI":"10.1056\/NEJMoa011573","volume":"346","author":"H Kantarjian","year":"2002","unstructured":"Kantarjian, H. et al. Hematologic and cytogenetic responses to imatinib mesylate in chronic myelogenous leukemia. N. Engl. J. Med. 346, 645\u2013652 (2002).","journal-title":"N. Engl. J. Med."},{"key":"BFnm1903_CR18","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1016\/j.ccr.2005.01.007","volume":"7","author":"E Weisberg","year":"2005","unstructured":"Weisberg, E. et al. Characterization of AMN107, a selective inhibitor of native and mutant Bcr-Abl. Cancer Cell 7, 129\u2013141 (2005).","journal-title":"Cancer Cell"},{"key":"BFnm1903_CR19","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1196\/annals.1378.038","volume":"1090","author":"A Brozik","year":"2006","unstructured":"Brozik, A. et al. Reduction of Bcr-Abl function leads to erythroid differentiation of K562 cells via downregulation of ERK. Ann. NY Acad. Sci. 1090, 344\u2013354 (2006).","journal-title":"Ann. NY Acad. Sci."},{"key":"BFnm1903_CR20","doi-asserted-by":"publisher","first-page":"370","DOI":"10.1002\/jcp.10426","volume":"198","author":"K Kohmura","year":"2004","unstructured":"Kohmura, K., Miyakawa, Y., Kawai, Y., Ikeda, Y. & Kizaki, M. Different roles of p38 MAPK and ERK in STI571-induced multi-lineage differentiation of K562 cells. J. Cell. Physiol. 198, 370\u2013376 (2004).","journal-title":"J. Cell. Physiol."},{"key":"BFnm1903_CR21","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1038\/nature04304","volume":"439","author":"DB Solit","year":"2006","unstructured":"Solit, D.B. et al. BRAF mutation predicts sensitivity to MEK inhibition. Nature 439, 358\u2013362 (2006).","journal-title":"Nature"},{"key":"BFnm1903_CR22","doi-asserted-by":"publisher","first-page":"16153","DOI":"10.1073\/pnas.0607973103","volume":"103","author":"RA O'Neill","year":"2006","unstructured":"O'Neill, R.A. et al. Isoelectric focusing technology quantifies protein signaling in 25 cells. Proc. Natl. Acad. Sci. USA 103, 16153\u201316158 (2006).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"BFnm1903_CR23","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1016\/S1097-2765(00)80367-6","volume":"4","author":"DW Felsher","year":"1999","unstructured":"Felsher, D.W. & Bishop, J.M. Reversible tumorigenesis by MYC in hematopoietic lineages. Mol. Cell 4, 199\u2013207 (1999).","journal-title":"Mol. Cell"},{"key":"BFnm1903_CR24","doi-asserted-by":"publisher","first-page":"2797","DOI":"10.1182\/blood-2002-10-3091","volume":"101","author":"A Karlsson","year":"2003","unstructured":"Karlsson, A. et al. Genomically complex lymphomas undergo sustained tumor regression upon MYC inactivation unless they acquire novel chromosomal translocations. Blood 101, 2797\u20132803 (2003).","journal-title":"Blood"},{"key":"BFnm1903_CR25","doi-asserted-by":"publisher","first-page":"16266","DOI":"10.1073\/pnas.0608017103","volume":"103","author":"S Giuriato","year":"2006","unstructured":"Giuriato, S. et al. Sustained regression of tumors upon MYC inactivation requires p53 or thrombospondin-1 to reverse the angiogenic switch. Proc. Natl. Acad. Sci. USA 103, 16266\u201316271 (2006).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"BFnm1903_CR26","doi-asserted-by":"publisher","first-page":"2674","DOI":"10.1182\/blood-2006-09-048033","volume":"110","author":"CM Shachaf","year":"2007","unstructured":"Shachaf, C.M. et al. Inhibition of HMGcoA reductase by atorvastatin prevents and reverses MYC-induced lymphomagenesis. Blood 110, 2674\u20132684 (2007).","journal-title":"Blood"},{"key":"BFnm1903_CR27","doi-asserted-by":"publisher","first-page":"2085","DOI":"10.1002\/1097-0142(19881115)62:10<2085::AID-CNCR2820621003>3.0.CO;2-R","volume":"62","author":"S Mitani","year":"1988","unstructured":"Mitani, S., Sugawara, I., Shiku, H. & Mori, S. Expression of c-myc oncogene product and ras family oncogene products in various human malignant lymphomas defined by immunohistochemical techniques. Cancer 62, 2085\u20132093 (1988).","journal-title":"Cancer"},{"key":"BFnm1903_CR28","doi-asserted-by":"publisher","first-page":"1643","DOI":"10.1016\/0277-5379(91)90436-H","volume":"27","author":"AD Wennborg","year":"1991","unstructured":"Wennborg, A.D., Altiok, E., Moore, J.P., Ernberg, I. & Klein, G. Differential c-myc protein expression in Burkitt's lymphomas and EBV-transformed lymphoblastoid lines. Eur. J. Cancer 27, 1643\u20131645 (1991).","journal-title":"Eur. J. Cancer"},{"key":"BFnm1903_CR29","doi-asserted-by":"publisher","first-page":"1038","DOI":"10.1002\/gcc.20606","volume":"47","author":"NA Johnson","year":"2008","unstructured":"Johnson, N.A. et al. Prognostic significance of secondary cytogenetic alterations in follicular lymphomas. Genes Chromosom. Cancer 47, 1038\u20131048 (2008).","journal-title":"Genes Chromosom. Cancer"},{"key":"BFnm1903_CR30","doi-asserted-by":"publisher","first-page":"2486","DOI":"10.1128\/MCB.4.11.2486","volume":"4","author":"SR Hann","year":"1984","unstructured":"Hann, S.R. & Eisenman, R.N. Proteins encoded by the human c-myc oncogene: differential expression in neoplastic cells. Mol. Cell. Biol. 4, 2486\u20132497 (1984).","journal-title":"Mol. Cell. Biol."},{"key":"BFnm1903_CR31","doi-asserted-by":"publisher","first-page":"7742","DOI":"10.1073\/pnas.81.24.7742","volume":"81","author":"G Ramsay","year":"1984","unstructured":"Ramsay, G., Evan, G.I. & Bishop, J.M. The protein encoded by the human proto-oncogene c-myc. Proc. Natl. Acad. Sci. USA 81, 7742\u20137746 (1984).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"BFnm1903_CR32","doi-asserted-by":"publisher","first-page":"1136","DOI":"10.1182\/blood.V99.4.1136","volume":"99","author":"SL Barrans","year":"2002","unstructured":"Barrans, S.L. et al. Germinal center phenotype and bcl-2 expression combined with the International Prognostic Index improves patient risk stratification in diffuse large B-cell lymphoma. Blood 99, 1136\u20131143 (2002).","journal-title":"Blood"},{"key":"BFnm1903_CR33","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1182\/blood-2002-04-1286","volume":"101","author":"L Colomo","year":"2003","unstructured":"Colomo, L. et al. Clinical impact of the differentiation profile assessed by immunophenotyping in patients with diffuse large B-cell lymphoma. Blood 101, 78\u201384 (2003).","journal-title":"Blood"},{"key":"BFnm1903_CR34","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1182\/blood.V90.1.244","volume":"90","author":"RD Gascoyne","year":"1997","unstructured":"Gascoyne, R.D. et al. Prognostic significance of Bcl-2 protein expression and Bcl-2 gene rearrangement in diffuse aggressive non-Hodgkin's lymphoma. Blood 90, 244\u2013251 (1997).","journal-title":"Blood"},{"key":"BFnm1903_CR35","doi-asserted-by":"publisher","first-page":"3818","DOI":"10.1182\/blood-2008-02-138933","volume":"112","author":"KR Calvo","year":"2008","unstructured":"Calvo, K.R. et al. IL-4 protein expression and basal activation of Erk in vivo in follicular lymphoma. Blood 112, 3818\u20133826 (2008).","journal-title":"Blood"},{"key":"BFnm1903_CR36","doi-asserted-by":"publisher","first-page":"762","DOI":"10.1097\/00000478-200306000-00006","volume":"27","author":"FI Camacho","year":"2003","unstructured":"Camacho, F.I. et al. Nodal marginal zone lymphoma: a heterogeneous tumor: a comprehensive analysis of a series of 27 cases. Am. J. Surg. Pathol. 27, 762\u2013771 (2003).","journal-title":"Am. J. Surg. Pathol."},{"key":"BFnm1903_CR37","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1182\/blood.V87.1.299.299","volume":"87","author":"J Dierlamm","year":"1996","unstructured":"Dierlamm, J. et al. Marginal zone B-cell lymphomas of different sites share similar cytogenetic and morphologic features. Blood 87, 299\u2013307 (1996).","journal-title":"Blood"},{"key":"BFnm1903_CR38","doi-asserted-by":"publisher","first-page":"3135","DOI":"10.1182\/blood-2006-02-003921","volume":"108","author":"JM Irish","year":"2006","unstructured":"Irish, J.M., Czerwinski, D.K., Nolan, G.P. & Levy, R. Altered B-cell receptor signaling kinetics distinguish human follicular lymphoma B cells from tumor-infiltrating nonmalignant B cells. Blood 108, 3135\u20133142 (2006).","journal-title":"Blood"},{"key":"BFnm1903_CR39","doi-asserted-by":"publisher","first-page":"e1000013","DOI":"10.1371\/journal.pcbi.1000013","volume":"4","author":"T Lee","year":"2008","unstructured":"Lee, T., Yao, G., Nevins, J. & You, L. Sensing and integration of Erk and PI3K signals by Myc. PLOS Comput. Biol. 4, e1000013 (2008).","journal-title":"PLOS Comput. Biol."},{"key":"BFnm1903_CR40","doi-asserted-by":"publisher","first-page":"3635","DOI":"10.1093\/nar\/gkg584","volume":"31","author":"JC Obenauer","year":"2003","unstructured":"Obenauer, J.C., Cantley, L.C. & Yaffe, M.B. Scansite 2.0: Proteome-wide prediction of cell signaling interactions using short sequence motifs. Nucleic Acids Res. 31, 3635\u20133641 (2003).","journal-title":"Nucleic Acids Res."}],"container-title":["Nature Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/nm.1903.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/nm.1903","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/nm.1903.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,18]],"date-time":"2023-05-18T22:23:01Z","timestamp":1684448581000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/nm.1903"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,4,12]]},"references-count":40,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2009,5]]}},"alternative-id":["BFnm1903"],"URL":"https:\/\/doi.org\/10.1038\/nm.1903","relation":{},"ISSN":["1078-8956","1546-170X"],"issn-type":[{"value":"1078-8956","type":"print"},{"value":"1546-170X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,4,12]]}}}